Pulmonary hypertension in mitral regurgitation

Journal of the American Heart Association

Volumn 3, Issue 4, 2014, Pages

  Patel, Harsh ^a   Desai, Milind ^a   Murat Tuzcu, E ^a   Griffin, Brian ^a   Kapadia, Samir ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL CLIP; CARDIOVASCULAR PARAMETERS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HEART CATHETERIZATION; HEART VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; IMPLANTABLE CLIP; LUNG BLOOD VESSEL; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT SAFETY; PEROPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL APPROACH; TREATMENT INDICATION; COMPLICATION; HYPERTENSION, PULMONARY; MITRAL VALVE INSUFFICIENCY; PATHOPHYSIOLOGY;

HUMANS; HYPERTENSION, PULMONARY; MITRAL VALVE INSUFFICIENCY;

EID: 84923190535     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.113.000748     Document Type: Review

References (59)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-1011.
2. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-1243.
3. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84-e231.
4. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268.
5. Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease-natural history and results of surgery. Br Heart J. 1975;37:74-78.
6. Bentivoglio L, Uricchio JF, Likoff W. The paradox of right ventricular enlargement in mitral insufficiency. Am J Med. 1958;4:193.
7. Ross J Jr, Braunwald E, Morrow AG. Clinical and hemodynamic observations in pure mitral insufficiency. Am J Cardiol. 1958;2:11-23.
8. Brandenburg RO, Fuster V, Giuliani ER, McGoon DC. Cardiology: Fundamentals and Practice. Chicago, London: Year Book Medical Publishers, Inc; 1987; 13:8-9.
9. Alexopolous D, Lazzam C, Borrico S, Fiedler E, Ambrose J. Isolated chronic mitral regurgitation with preserved systolic left ventricular function and severe pulmonary hypertension. J Am Coll Cardiol. 1989;14:319-322.
10. Barbieri A, Bursi F, Grigioni F, Avierinos JF, Michelena HI, Rusinaru D, Szymansky C, Russo A, Suri R, Bacchi Reggiani ML, Branzi A, Modena MG, Enriquez-Sarano M; MIDA Investigators. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J. 2011;32:751-759
11. Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants of pulmonary hypertension in left ventricular dysfunction. JAMA. 1997;29: 153-159.
12. Marechaux S, Neicu D, Braun S, Richardson M, Delsart P, Bouabdallaoui N, Banfi C, Gautier C, Graux P, Asseman P, Pibarot P, Le Jemtel TH, Ennezat PV; Lille HFpEF Study Group. Functional mitral regurgitation: a link to pulmonary hypertension in heart failure with preserved ejection fraction. J Cardiac Fail. 2011;17:806-812.
13. Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation. 2008;118:2298-2303.
14. Braunwald E. Mitral regurgitation: physiologic, clinical and surgical considerations. N Engl J Med. 1969;281:425-433.
15. West JB, Mathieu-Costello O. Vulnerability of pulmonary capillaries in heart disease. Circulation. 1995;92:622-631.
16. Tsukimoto K, Mathieu-Costello O, Prediletto R, Elliott AR, West JB. Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J Appl Physiol. 1991;71:573-582.
17. Townsley MI, Fu Z, Mathieu-Costello O, West JB. Pulmonary microvascular permeability. Responses to high vascular pressure after induction of pacinginduced heart failure in dogs. Circ Res. 1995;77:317-325.
18. Guazzi M. Alveolar gas diffusion abnormalities in heart failure. J Card Fail. 2008;14:695-702.
19. Rich S, Rabinovitch M. Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. Circulation. 2008;118:2190-2199.
20. Wagenvoort C, Wagenvoort N. Pathology of Pulmonary Hypertension. 2nd ed. New York, NY: John Wiley & Sons; 1977.
21. Ooi H, Colucci WS, Givertz MM. Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan. Circulation. 2002;106:1618-1621.
22. Cooper CJ, Jevnikar FW, Walsh T, Dickinson J, Mouhaffel A, Selwyn AP. The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure. Am J Cardiol. 1998;82:609-614.
23. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85:504-509.
24. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493-2537.
25. Foltz BD, Hessel EA II, Ivey TD. The early course of pulmonary artery hypertension in patients undergoing mitral valve replacement with cardioplegic arrest. J Thorac Cardiovasc Surg. 1984;88:238-247.
26. Morrow AG, Oldham HN, Elkins RS, Braunwald E. Prosthetic replacement of mitral valve. Preoperative and postoperative clinical and hemodynamic assessments in 100 patients. Circulation. 1967;35:962-979.
27. Tempe DK, Hasija S, Datt V, Tomar AS, Virmani S, Banerjee A, Pande B. Evaluation and comparison of early hemodynamic changes after elective mitral valve replacement in patients with severe and mild pulmonary arterial hypertension. J Cardiothorac Vasc Anesth. 2009;23:298-305.
28. Kondo RP, Dederko DA, Teutsch C, Chrast J, Catalucci D, Chien KR, Giles WR. Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform. J Physiol. 2006;571:131-146.
29. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation. 2009;120:992-1007.
30. Dini FL, Conti U, Fontanive P, Andreini D, Banti S, Braccini L, De Tommassi SM. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am Heart J. 2007;154:172-179.
31. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183-188.
32. Howard LS, Grapsa J, Dawson D, Bellamy M, Chambers JB, Masani ND, Nihoyannopoulos P, Simon R, Gibbs J. Echocardiographic assessment of pulmonary hypertension: standard operating procedure. Eur Respir Rev. 2012;21:239-248.
33. Currie PJ, Seward JB, Chan KL, Fyfe DA, Hagler DJ, Mair DD, Reeder GS, Nishimura RA, Tajik AJ. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750-756.
34. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, Corretti MC, Hassoun PM. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179:615-621.
35. Fisher MR, Criner GJ, Fishman AP, Hassoun PM, Minai OA, Scharf SM, Fessler AH. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J. 2007;30:914-921.
36. Granstam SO, Bjorklund E, Wikstrom G, Roos MW. Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension. Cardiovasc Ultrasound. 2013;11:7.
37. Corciova FC, Corciova C, Georgescu CA, Enache M, Anghel D, Bartos O, Tinica G. Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension. Heart Surg Forum. 2012;15:E127-E132.
38. Ghio S, Klersy C, Magrini G, D'Armini AM, Scelsi L, Raineri C, Pasotti M, Serio A, Campana C, Vigano M. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol. 2010;140:272-278.
39. Schiller NB. Exercise Doppler echocardiography in valvular and noncoronary myocardial disease. Interventional echocardiography: transesophageal, pharmacologic and intravascular. ACC Learn Cent Highlights 8.1994.
40. Magne J, Lancellotti P, Pierard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation. 2010;122:33-41.
41. Leung DY, Griffin BP, Stewart WJ, Cosgrove DM III, Thomas JD, Marwick TH. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol. 1996;28:1198-1205.
42. Lancellotti P, Cosyns B, Zacharakis D, Attena E, Van Camp G, Gach O, Radermecker M, Pierard LA. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr. 2008;21:1331-1336.
43. Magne J, Mahjoub H, Dulgheru R, Pibarot P, Pierard L, Lancellotti P. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. Eur Heart J. 2013;35:1608-1616.
44. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest. 2009;136:37-43.
45. Healy DG, Veerasingam D, McHale J, Luke D. Successful perioperative utilisation on inhaled nitric oxide in mitral valve surgery. J Cardiovasc Surg. 2006;47:217-220.
46. Yurtseven N, Karaca P, Uysal G, Ozkul V, Cimen S, Tuygun AK, Yuksek A, Canik S. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery. Ann Thorac Cardiovasc Surg. 2006;12:319-323.
47. Suga H, Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res. 1974;35:117-126.
48. Cassidy SC, Teitel DF. The conductance volume catheter technique for measurement of left ventricular volume in young piglets. Pediatr Res. 1992;31: 85-90.
49. Baan J, van der Velde ET, de Bruin HG, Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation. 1984;70:812-823.
50. Lim DS, Gutgesell HP, Rocchini AP. Left ventricular function by pressurevolume loop analysis before and after percutaneous repair of large atrial septal defects. Catheter Cardiovasc Interv. 2006;67:788-838.
51. Kim YJ, Jones M, Greenberg NL, Popovic ZB, Sitges M, Bauer F, Thomas JD, Shiota T. Evaluation of left ventricular contractile function using noninvasively determined single-beat end-systolic elastance in mitral regurgitation: experimental validation and clinical application. J Am Soc Echocardiogr. 2007;20: 1086-1092.
52. Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA, O'Gara PT, O'Rourke A, Rahimtoola SH, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Gibbons RJ, Russell RO, Ryan TJ, Smith SC Jr. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 1998;98:1949-1984.
53. Crawford MH, Souchek J, Oprian CA, Miller DC, Rahimtoola S, Giacomini JC, Sethi G, Hammermeister KE. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation. 1990;81:1173-1181.
54. Yang H, Davidson WR Jr, Chambers CE, Pae WE, Sun B, Chambpell DB, Pu M. Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: an echocardiographic and hemodynamic study. J Am Soc Echocardiogr. 2006;19:1051-1055.
55. Le Tourneau T, Richardson M, Juthier F, Modine T, Fayad G, Polge AS, Ennezat PV, Bauters C, Vincentelli A, Deklunder G. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart. 2010;96:1311-1317.
56. Kainuma S, Taniguchi K, Toda K, Funatsu T, Kondoh H, Nishino M, Daimon T, Sawa Y. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation. J Thorac Cardiovasc Surg. 2011;142:783-792.
57. Ghoreishi M, Evans CF, Defilippi CR, Hobbs G, Young CA, Griffith BP, Gammie JS. Pulmonary hypertension adversely affects short-and longterm survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg. 2011;142: 1439-1452.
58. Kang DH, Kim JH, Rim JH, Kim MJ, Yun SC, Song JM, Song H, Choi KJ, Song JK, Lee JW. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation. 2009;119:797-804.
59. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395-1406.